Lipocalin 2 is essential for chronic kidney disease progression in mice and humans

Mechanisms of progression of chronic kidney disease (CKD), a major health care burden, are poorly understood. EGFR stimulates CKD progression, but the molecular networks that mediate its biological effects remain unknown. We recently showed that the severity of renal lesions after nephron reduction...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Viau, Amandine, El Karoui, Khalil, Laouari, Denise, Burtin, Martine, Nguyen, Clément, Mori, Kiyoshi, Pillebout, Evangéline, Berger, Thorsten, Mak, Tak Wah, Knebelmann, Bertrand, Friedlander, Gérard, Barasch, Jonathan, Terzi, Fabiola
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Clinical Investigation 2010
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2964970/
https://ncbi.nlm.nih.gov/pubmed/20921623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI42004
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים